Acceptability and delivery of an offer of access to EMDR for depression, posttraumatic stress, and burnout in healthcare workers exposed to COVID-19: a randomized controlled trial within a cohort
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Healthcare workers (HCWs) were highly exposed to COVID-19 and often experienced anxiety, depression, burnout, and posttraumatic stress disorder (PTSD). The HARD trial assessed the effect of being offered access to EMDR therapy on HCWs with COVID-19-related psychological symptoms. This cohort-embedded randomized trial enrolled 849 HCWs exposed to COVID-19. Participants completed online assessments every 3 months for 12 months. Those scoring above predefined thresholds for PTSD, depression, or burnout were randomized (1:1) to an offer of access to EMDR or to usual care alone. Outcomes compared 6-month changes in PTSD, depression, and burnout symptoms, and EMDR compliance was evaluated. A total of 237 eligible cohort participants were randomized in the HARD trial. Among the 118 subjects of the intervention offer, 73 (62%) consented to EMDR sessions, and of these, 38 (52%) received EMDR sessions (median 7, IQR 4 to 12 sessions). Primary analysis estimated a mean difference between groups from baseline to 6 months post-randomization of -0.61 (p = 0.77) for the PTSD score, -1.17 (p = 0.18) for the depression score, and 0.32 (p = 0.72) for the burnout subdimension. Improvements favoring the intervention offer group were observed for depressive symptoms and PTSD avoidance at 12 months. In this pragmatic trial, uptake and adherence to an offer of EMDR among symptomatic HCWs were limited. No statistically significant between-group differences were detected in the prespecified six-month primary outcomes, although the study recruited substantially fewer participants than planned and was therefore underpowered, treatment exposure varied substantially, and the intervention was not subject to systematic fidelity monitoring. These findings primarily provide information about real-world acceptability (a modest 62% consent rate) and delivery (only 52% of consenting participants used the intervention). Our ability to draw conclusions about potential effectiveness of EMDR, if used, however, was limited by the law rate of consent to access the intervention among those offered program access and the law rate of usage among those who did not consent.
Source: Scientific Reports
Authors: Wissam El-Hage, Laurène Mansy, Valérie Gissot, Myriam Blanchin, Lyna Chami, Antoine Bray, Coraline Hingray, Philippe Birmes, Chantal Bergey, Bénédicte Gohier, Eric Fakra, Anne Sauvaget, Cédric Lemogne, Marie-Odile Krebs, Bruno Aouizerate, Isabelle Jalenques, Pierre Vidailhet, Nathalie Prieto, Eric Bui, Agnès Caille
Institutions: Université de Tours, Inserm, Imaging, Brain, and Neuropsychiatry, Centre Hospitalier Universitaire de Tours, Clinical Investigation Center Plurithematic Tours, methodS in Patient-centered outcomes and HEalth ResEarch, Université de Nantes, Nantes Université, Université Toulouse III - Paul Sabatier, Université de Toulouse, Toulouse NeuroImaging Center, Centre Hospitalier Charles Perrens, Laboratoire de Psychologie des Pays de la Loire, Centre Hospitalier Universitaire d'Angers, Université d'Angers, Centre Hospitalier Universitaire de Saint-Étienne, Centre Hospitalier Universitaire de Nantes, Laboratoire Motricité, Interactions, Performance, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Institut de Psychiatrie et Neurosciences de Paris, Hôtel-Dieu de Paris, Université Paris Descartes, Institut Pascal, Clermont Auvergne INP, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Hôpital Edouard Herriot, Centre Hospitalier Universitaire de Caen Normandie, Université de Caen Normandie
Language: English
Topic: COVID-19 and Mental Health
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7223016597
